The weight loss space is dominated by Eli Lilly and Novo Nordisk, which produce the leading medications. Viking Therapeutics, Altimmune, Pfizer, and Roche are all looking to enter the red-hot weight loss space. The popularity surrounding weight loss drugs such as Mounjaro and Ozempic has brought Eli Lilly and Novo...

Are Eli Lilly and Novo Nordisk Too Expensive For You? Here Are 4 Other Potential Weight Loss Stocks You May Want to Consider Right Now.

(Reuters) -Pfizer plans to move a reworked, once-a-day version of its weight-loss pill danuglipron into clinical trials later this year, the company said on Thursday, after scrapping a twice- daily version of the drug late last year. The new drug is part of the second generation of weight-loss pills under...

Pfizer Moves Forward With Once-Daily Weight-Loss Pill

Patients taking Eli Lilly's new drug Mounjaro achieved significantly greater weight loss than those on Novo Nordisk's Ozempic, a head-to-head study published Monday showed.  Most patients achieved five percent or greater weight loss after a year, but those on Mounjaro were more likely to lose weight and achieved greater weight loss. 

Eli Lilly weight loss drug beats Ozempic in head-to-head study

Johnson & Johnson has been generating decent growth, but legal challenges could create a lot of uncertainty. Abbott Laboratories has a more diverse business, with some exciting opportunities in diabetes care. The company recently obtained clearance for a couple of new glucose monitoring systems. Abbott Laboratories' growth rate may look...

Forget Johnson & Johnson: Another Healthcare Giant Is a Much Better Bet for Growth

First For Women

Healthcare company Roche said its trial-stage daily pill showed an average 6.1 percent weight loss in four weeks

A New Ozempic Pill? Roche Shakes Up the Weight Loss Drug Market With Promising Results: See The Data

COLUMBIA, Mo. — All cancers are difficult to treat, and blood cancers are among the trickiest to handle. However, a common high blood pressure drug is helping to weaken leukemia’s defenses against chemotherapy. Researchers from the University of Missouri School of Medicine are using losartan in a new...

Common high blood pressure drug losartan boosts chemotherapy’s ability to beat leukemia

A healthy 38-year-old who began struggling to finish a half-marathon and experienced night sweats, body aches, and COVID-like symptoms learned he was facing stage 4 non-Hodgkin lymphoma. Despite the shocking diagnosis, he plans to remain positive while he fights the cancer. Lymphoma is a blood cancer, specifically of the immune...

Fit, Healthy Man, 38, With Swollen Knee Felt Covid-Like Symptoms for a Month Before Learning He Had Stage 4 Non-Hodgkin Lymphoma

According to experts at the Cleveland Clinic, “When it comes to testosterone levels, odds are you don’t measure up to your father. Studies show that age-specific testosterone levels in men have been in a slow and consistent decline for several decades.”. In other words, the average level of...

3 health conditions that steal your testosterone

New York City, NY

Writers represent independent, third-party users who have joined our contributor program and self-verified their accounts. Writers are expected, like all users, to adhere to our Community Standards.

writer

Cheryl E Preston

Yesterday was the third time this year that an ad stating Chelsea Clinton lives in a beautiful Virginia home popped up on my laptop. My computer did not warn me this was a dangerous site, so this time, I clicked on the link.

Chelsea Clinton is rumored to be living in Virginia but probably still in NYC

Tropicamide had the strongest association with angle-closure glaucoma and was reported the most frequently, with 520 cases. Sulfonamides, serotonergic agents and antimuscarinic agents also showed signals. Perspective from Joe L. Wheat, OD, PhD, FAAO. Eighteen medications appeared to be associated with angle-closure glaucoma, including sulfonamides, serotonergic agents and antimuscarinic agents,...

Researchers identify 18 drugs associated with angle-closure glaucoma

Everyday Health

Who should receive Ozempic and GLP-1 drugs given their high demand and limited supply? Experts debate prioritizing those with diabetes, obesity, and cardiovascular risks to maximize public health benefits.

Ozempic and GLP-1 Drugs Are in Short Supply: Who Deserves Them Most?

Biologics work by targeting proteins that cause inflammation in ulcerative colitis. As a result, certain biologics help decrease flare-ups and complications. There are four types of biologics identified in the treatment of ulcerative colitis: anti-tumor necrosis factor (TNF) agents, integrin receptor antagonists, interleukin inhibitors, and Janus kinase (JAK) inhibitors. Biologics...

4 Types of Biologics Used for Ulcerative Colitis

The average American believes they'll need to save $1.8 million for their post-work years, according to Charles Schwab's "2024 401(k) Participant Study." However, most Americans in their 50s have much less than that stashed away for retirement. The average 401(k) account balance for people in their 50s is $212,400, as...

Here’s how much money Americans in their 50s have in their 401(k)s

Chicago, IL

Foodie in Chicago

Shortly before 3 AM, people in the Chicago area may have felt their houses shake as a 3.4-magnitude earthquake occurred about 60 miles west of the city. (CHICAGO) The United States Geological Survey (USGS) reported a 3.4-magnitude earthquake around Somonauk, IL. Somonauk is in DeKalb and LaSalle Counties, 64 miles west of Chicago.

Did You Feel the Earthquake?

Ozempic has been called Hollywood’s 'worst kept secret' for weight loss, but is it safe for everyone?

Worried About ‘Ozempic Face’? What an MD Wants You to Know about Ozempic Side Effects

President Joe Biden is making another move to forgive student debt for millions of borrowers. The Biden-Harris administration announced Wednesday that it will begin emailing borrowers on Thursday with information regarding its proposed rules to allow the Secretary of Education to forgive debt for certain federal student loan borrowers. The...

President Biden is moving forward with another student debt relief plan—you have until August 30 to opt out

Alabama State

Living in major U.S. cities means higher housing costs and less space for your money. And when the covid-19 pandemic sparked the rise of remote work, it caused many workers to second-guess living in a major metropolis like New York and San Francisco. Though some companies continue to push in-office...

6 places across the U.S. that will pay you thousands of dollars to move there

Chronic lymphocytic leukemia (CLL) is a type of cancer that affects the blood and bone marrow. It can progress slowly and may not cause many symptoms. Although it is treatable, it’s not considered to be curable. In the early stages, CLL often doesn't require treatment immediately, as studies have...

Chronic Lymphocytic Leukemia (CLL): When to Treat Cancer or Hold Off

The Independent

Hundreds of blood cancer patients will be able to access a ‘game changer’ drug which will allow them to be treated at home, it has been announced. The drug is the first ever ‘take-at-home’ tablet to be approved to treat blood cancer patients, according to an announcement from NHS England. Patients in England with marginal zone lymphoma (MZL) can be offered the drug, called zanubrutinib, where they have not responded well to previous treatments. The National Institute for Health and Care Excellence (NICE) recommended the use of the drug on the NHS from 1 August. In clinical trials, up to...

‘Game changer’ take home blood cancer drug to be offered to hundreds of NHS patients

A second dendritic cell vaccine has received fast track designation from the Food and Drug Administration. The Food and Drug Administration (FDA) has granted a fast track designation to a dendritic cell vaccine for the treatment of patients with pancreatic ductal adenocarcinoma. Immuno-oncology company Diakonos Oncology Corporation announced the designation...

FDA Fast Tracks Pancreatic Cancer Vaccine

NewsBreak

Swiss pharma giant Roche to accelerate Wegovy rival drugs after positive trial data

Swiss pharmaceutical giant Roche said Monday it is accelerating the development of its Wegovy rival weight loss drugs following promising early stage trial data. The company's...

Swiss pharma giant Roche to accelerate Wegovy rival drugs after positive trial data

Comments / 0